MOSCOW (Sputnik) — There has been no evidence of the dangerous drug scopolamine, also known as Devil’s Breath, being used in Europe to date, European Monitoring Centre for Drugs and Drug Addition (EMCDDA) told Sputnik on Tuesday.
"No detections of scopolamine have been reported to the EU EWS [Early Warning System] by the 28 Member States, Turkey and Norway, as of yet," Rachel Christie from the Action on New Drugs Unit at EMCDDA said.
The UK government has issued a travel warning to those traveling to Colombia, in which it claims that the British Embassy has received reports of criminals in Colombia using drugs, including scopolamine, to subdue their victims.
Christie explained that EMCDDA plays a central role in Europe’s response to new psychoactive substances, and its main task is to operate the EU Early Warning System and Europol to undertake risk assessments of new substances, as necessary.
